InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（4 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Walker Karin L, Directeur Comptable. Insider active across 3 companies, notably Cyclacel Pharmaceuticals, Inc.. Aggregated, 28 filings have been published. Split: 0 buy · 4 sells. Activity tracked since 15 June 2021. The latest transaction was filed on 28 July 2026 (Disposition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Walker Karin L
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报28 总计
15,000 股Ordinary Shares, par value $0.01 per shareSEC:0000905148-26-003416:0
15,000 股@ US$8.560.029% mcap6.0% 占其流量Ordinary Shares, par value $0.01 per shareSEC:0000905148-26-003416:1
25,000 股0Ordinary Shares, par value $0.01 per shareSEC:0000905148-25-002661:0
5,000 股@ US$13.533.0% 占其流量Ordinary Shares, par value $0.01 per shareSEC:0000905148-24-000282:0
5,000 股@ US$13.532.9% 占其流量Ordinary Shares, par value $0.01 per shareSEC:0000905148-23-001682:0
5,000 股@ US$13.532.9% 占其流量Ordinary Shares, par value $0.01 per shareSEC:0000905148-23-001531:0
5,000 股@ US$13.533.0% 占其流量Ordinary Shares, par value $0.01 per shareSEC:0000905148-23-001201:0
5,000 股@ US$15.043.7% 占其流量Ordinary Shares, par value $0.01 per shareSEC:0000905148-23-000946:0
5,000 股@ US$15.043.3% 占其流量Ordinary Shares, par value $0.01 per shareSEC:0000905148-23-000772:0
5,000 股@ US$15.043.2% 占其流量Ordinary Shares, par value $0.01 per shareSEC:0001140361-23-035280:0
21,219 股0Common StockSEC:0001104659-23-077655:0
5,000 股@ US$15.043.3% 占其流量Ordinary Shares, par value $0.01 per shareSEC:0001140361-23-030563:0
5,000 股@ US$15.043.3% 占其流量Ordinary Shares, par value $0.01 per shareSEC:0001140361-23-025833:0
5,000 股@ US$15.043.3% 占其流量Ordinary Shares, par value $0.01 per shareSEC:0001140361-23-019684:0
5,000 股@ US$15.043.4% 占其流量Ordinary Shares, par value $0.01 per shareSEC:0001140361-23-013190:0
20,000 股@ US$15.0413.3% 占其流量Ordinary Shares, par value $0.01 per shareSEC:0001567619-23-005293:0
10,000 股@ US$15.046.9% 占其流量Ordinary Shares, par value $0.01 per shareSEC:0001567619-22-020647:0
20,000 股@ US$15.0414.5% 占其流量Ordinary Shares, par value $0.01 per shareSEC:0001567619-22-018818:0
15,822 股0Common StockSEC:0001104659-22-071903:0
4,519 股@ US$15.043.4% 占其流量Ordinary Shares, par value $0.01 per shareSEC:0001567619-21-021197:0
20,000 股@ US$15.0414.5% 占其流量Ordinary Shares, par value $0.01 per shareSEC:0001567619-21-018621:0
2,374 股0Common StockSEC:0001104659-21-082598:0
2,000 股Ordinary Shares, par value $0.01 per shareSEC:0000899243-16-011804:0
500 股Ordinary Shares, par value $0.01 per shareSEC:0000899243-16-011804:2
2,000 股Ordinary Shares, par value $0.01 per shareSEC:0000899243-16-011804:3
28 条申报中的 25 条
About Walker Karin L
Walker Karin L is Chief Accounting Officer and has filed 26 transactions in total. Across the 26 recent filings we hold, the aggregated amounts are EUR 0 for buys and EUR 0 for sells, with Levée d'options as the most frequent transaction nature, and the filings run from 2016-01-15 to 2025-07-30. They are linked to Prothena CORP Public Ltd Co, Prothena Corp plc, and Cyclacel Pharmaceuticals, Inc., and the largest recorded filings concern Prothena CORP Public Ltd Co, including EUR 304253.1755854053 on 2022-10-26, EUR 280396.73319657 on 2023-03-17, and EUR 258086.3841861247 on 2021-10-22.
